BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2441930)

  • 1. Public epitopes and the antigenic structure of the HLA molecules.
    Rodey GE; Fuller TC
    Crit Rev Immunol; 1987; 7(3):229-67. PubMed ID: 2441930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules. Implications for Ia function and evolution.
    Braunstein NS; Germain RN; Loney K; Berkowitz N
    J Immunol; 1990 Sep; 145(6):1635-45. PubMed ID: 1697304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes.
    Wan AM; Ennis P; Parham P; Holmes N
    J Immunol; 1986 Dec; 137(11):3671-4. PubMed ID: 2431040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to human major histocompatibility complex class II antigens.
    Radka SF
    Crit Rev Immunol; 1987; 8(1):23-48. PubMed ID: 2446824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
    Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
    J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid residues 56 to 69 of HLA-A2 specify an antigenic determinant shared by HLA-A2 and HLA-B17.
    Ways JP; Rothbard JB; Parham P
    J Immunol; 1986 Jul; 137(1):217-22. PubMed ID: 2423602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocyte-defined epitope differences between HLA-A2.1 and HLA-A2.2 map to two distinct regions of the molecule.
    Hogan KT; Clayberger C; Le AX; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Dec; 141(11):4005-11. PubMed ID: 2460555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
    Burlingham WJ; Jankowska-Gan E; DeVito-Haynes L; Fechner JH; Hogan KT; Claas FH; Mulder A; Wang X; Ferrone S
    J Immunol; 1998 Dec; 161(12):6705-14. PubMed ID: 9862700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class II DQ epitopes.
    Deng CT; Cai J; Tarsitani C; El-Awar N; Lachmann N; Ozawa M
    Clin Transpl; 2006; ():115-22. PubMed ID: 18365373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antigenic structure of HLA-A2: an analysis with competitive binding assays and monoclonal antibodies.
    Ways JP; Parham P
    J Immunol; 1983 Aug; 131(2):856-63. PubMed ID: 6190942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of serologic recognition sites in the human HLA-A2 molecule.
    Santos-Aguado J; Barbosa JA; Biro PA; Strominger JL
    J Immunol; 1988 Oct; 141(8):2811-8. PubMed ID: 2459229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class II antigens: structure, function, and expression in immunodeficiencies, autoimmune diseases, and allograft rejection.
    Touraine JL; Bétuel H; Pouteil-Noble C; Royo C
    Adv Nephrol Necker Hosp; 1989; 18():325-34. PubMed ID: 2493721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of the HLA molecular structure to transplantation.
    Park MS; Terasaki PI; Barbetti A; Han H; Cecka JM
    Clin Transpl; 1988; ():301-28. PubMed ID: 2484900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens.
    El-Awar N; Lee JH; Tarsitani C; Terasaki PI
    Hum Immunol; 2007 Mar; 68(3):170-80. PubMed ID: 17349872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of novel class I histocompatibility antigens by interspecies exon shuffling.
    Engelhard VH; Yannelli JR; Evans GA; Walk SF; Holterman MJ
    J Immunol; 1985 Jun; 134(6):4218-25. PubMed ID: 2985705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of high sensitization to the structure of HLA class I alleles.
    Clark BD; Geer LI; Park MS; Terasaki PI
    Clin Transpl; 1991; ():347-62. PubMed ID: 1726461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.